Improving survival in ACLF: growing evidence for use of G-CSF

被引：14
|
作者：
Simonetto, D. A. [1 ]
Shah, V. H. [1 ]
Kamath, P. S. [1 ]
机构：
[1] Mayo Clin, Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源：
HEPATOLOGY INTERNATIONAL | 2017年 / 11卷 / 06期
关键词：
COLONY-STIMULATING FACTOR; CHRONIC LIVER-FAILURE; HEPATIC PROGENITORS; THERAPY; CELLS;
D O I：
10.1007/s12072-017-9834-x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [1] G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLF
    Ortega-Ribera, Marti
    Zhuang, Yuan
    Brezani, Veronika
    Nagesh, Prashanth Thevkar
    Joshi, Radhika S.
    Babuta, Mrigya
    Wang, Yanbo
    Szabo, Gyongyi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [2] Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF
    Engelmann, Cornelius
    Habtesion, Abeba
    Hassan, Mohsin
    Kerbert, Annarein J. C.
    Hammerich, Linda
    Novelli, Simone
    Fidaleo, Marco
    Philips, Alexandra
    Davies, Nathan
    Ferreira-Gonzalez, Sofia
    Forbes, Stuart J.
    Berg, Thomas
    Andreola, Fausto
    Jalan, Rajiv
    JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1325 - 1338
  • [3] Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia
    Basnett, Jordan
    Xie, Vicki
    Cisterne, Adam
    Bradstock, Ken
    Bendall, Linda
    PLOS ONE, 2017, 12 (11):
  • [4] A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation
    Grosso, Dolores
    Leiby, Benjamin
    Wilde, Lindsay
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    O'Hara, William
    Wagner, John L.
    Mateja, Gina
    Alpdogan, Onder
    Binder, Adam
    Kasner, Margaret
    Keiffer, Gina
    Klumpp, Thomas
    Martinez, Ubaldo Outschoorn
    Palmisiano, Neil
    Porcu, Pierluigi
    Gergis, Usama
    Flomenberg, Neal
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (12): : 831.e1 - 831.e7
  • [5] G-CSF activation of AKT is not sufficient to prolong neutrophil survival
    Souza, Liliana R.
    Silva, Erica
    Calloway, Elissa
    Cabrera, Carlos
    McLemore, Morgan L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2013, 93 (06) : 883 - 893
  • [6] Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
    Bakherad, Hamid
    Setayesh, Neda
    Gargari, Seyed Latif Mousavi
    Ebrahimizadeh, Walead
    Mavandadnejad, Faranak
    Faghfuri, Elnaz
    Ebrahimi, Soheila
    Heiat, Mohammad
    Shahpari, Mona
    Sepehrizadeh, Zargham
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2020, 15 (04) : 381 - 389
  • [7] Old drug, new use: Recent advances for G-CSF
    Yan, Lun
    Li, Jing
    Yang, Yang
    Zhang, Xi
    Zhang, Cheng
    CYTOKINE, 2024, 184
  • [8] The Characterization and Potential use of G-CSF Dimers and their Pegylated Conjugates
    Fidler, Katarina
    Jevsevar, Simona
    Milunovic, Tatjana
    Skrajnar, Spela
    Premzl, Ales
    Kunstelj, Menci
    Zore, Irena
    Podobnik, Barbara
    Kusterle, Mateja
    Caserman, Simon
    Kenig, Maja
    Smilovic, Vanja
    Porekar, Vladka Gaberc
    ACTA CHIMICA SLOVENICA, 2011, 58 (01) : 1 - 8
  • [9] G-CSF and GM-CSF in Neutropenia
    Mehta, Hrishikesh M.
    Malandra, Michael
    Corey, Seth J.
    JOURNAL OF IMMUNOLOGY, 2015, 195 (04) : 1341 - 1349
  • [10] Optimal use of G-CSF administration after hematopoietic SCT
    Trivedi, M.
    Martinez, S.
    Corringham, S.
    Medley, K.
    Ball, E. D.
    BONE MARROW TRANSPLANTATION, 2009, 43 (12) : 895 - 908
12345